Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04592718 · ClinicalTrials.gov registry record · NA
Four-week Breathing Interventions on Gut Symptoms, Heart Rate Variability, and Psychological Measures in Runners
A NA study, sponsored by Old Dominion University.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT04592718: Completed NA study, sponsored by Old Dominion University.
NCT04592718 is a NA study that has completed, run by Old Dominion University. The registered enrollment target is 63 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04592718, a NA study, has completed, sponsored by Old Dominion University.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
Recent research has suggested that stress and anxiety levels are associated with gastrointestinal (GI) symptoms in endurance athletes (runners, cyclists, triathletes). Yet, there has been limited attempt to evaluate whether GI symptoms during running can be mitigated by interventions designed to reduce stress and anxiety. Thus, this study will evaluate the effects of four-week slow deep breathing and mindful breath counting interventions on subjective and objective measures of stress/anxiety and GI symptoms in runners with mild-to-high anxiety and that are prone to GI symptoms during runs.
Primary Outcome
Percentage of training runs that runners experience at least 1 gastrointestinal symptom (\>2 on 0-10 scale).
Interventions
- BEHAVIORAL Slow deep breathing plus breath counting
- BEHAVIORAL Normal-paced breathing plus breath counting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2020-10-20 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT04592718 record still lists
NCT04592718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Slow deep breathing plus breath counting is the first listed.
NCT04592718 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04592718 about?
NCT04592718 is a clinical study titled "Four-week Breathing Interventions on Gut Symptoms, Heart Rate Variability, and Psychological Measures in Runners". Recent research has suggested that stress and anxiety levels are associated with gastrointestinal (GI) symptoms in endurance athletes (runners, cyclists, triathletes). Yet, there has been limited attempt to evaluate whether GI symptoms during running can be mitigated by interventions designed to red...
What is the current status of trial NCT04592718?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2020-10-20. Estimated completion is 2021-06-30.
What interventions are being tested in trial NCT04592718?
The interventions under investigation include: Slow deep breathing plus breath counting (BEHAVIORAL), Normal-paced breathing plus breath counting (BEHAVIORAL).
Who is sponsoring clinical trial NCT04592718?
This trial is sponsored by Old Dominion University, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04592718's enrollment target sits among peer trials
63 1157th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI